Xavier Mirabel is an expert in Radiotherapy at Centre Oscar Lambret (France). Xavier Mirabel has authored 280 publications, the most recent in 2025, and is an investigator in 15 clinical trials, 2 of them ongoing. SLR score: 781 (community average: 125). How the SLR is computed.

LeadR Profile

Xavier Mirabel Centre Oscar Lambret France
781 ScienceLeadR Reputation 781
Network Map

Radiotherapy

Subspecialties: Oncology - Dermatology - Nuclear Medicine

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2004 - 2025

Source: PubMed

Centre Oscar Lambret

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 280

Citations

Citations: 5 317 1st author: 4 Last author: 31 Unique author: 1


Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Total-body irradiation-based versus chemotherapy alone as myeloablative conditioning regimen prior to hematopoietic allogeneic stem cell transplantation in adults with acute lymphoblastic leukemia: a multi-institutional study from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC).
PMID 41135711 — registries, cells, precursor cell lymphoblastic leukemia-lymphoma, bone marrow, microscopy, electron, scanning transmission, whole-body irradiation, bone marrow transplantation, multiple chronic conditions, leukemia, stem cells, drug therapy, radiobiology, therapeutics, cell transplantation, conditioning, psychological, stem cell transplantation, transplantation, chemotherapy
Int J Radiat Oncol Biol Phys20250
HDR and PDR brachytherapy for facial nonmelanoma skin cancer: Outcome and toxicity assessment for 155 patients.
PMID 40713198 — skin, cells, carcinoma, squamous cell, brachytherapy, neoplasms, wounds and injuries, skin neoplasms
Brachytherapy20250
What are the outcomes for long-term survivors after esophagectomy ? - Evidence from a randomized controlled trial (FFCD9901).
PMID 40120352 — neoplasms, multiple chronic conditions, esophageal neoplasms, medical oncology, esophagectomy
Eur J Surg Oncol20250
Extra- and intracranial schwannomas treated with fractionated stereotactic irradiation: Results of a retrospective, multicentric study.
PMID 40305880 — radiotherapy, therapeutics, neurilemmoma
Cancer Radiother20250
Radiotherapy and skin cancers - An essential collaboration for onco-dermatology.
PMID 40089382 — radiotherapy, skin, sexually transmitted diseases, neoplasms, dermatology, skin neoplasms
Ann Dermatol Venereol20250

Clinical Studies 15

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5 Study Director: 1

By phase:

N/A 6
Phase 2 5
Phase 3 3
Phase 1/Phase 2 1

By status:

Completed 7
Recruiting 4
Active not recruiting 2
Terminated 2

By type:

Interventional 15

By Monocentric/Multicentric:

monocentric 1
multicentric2to4 2
multicentric5to9 2
multicentricup10 10

Main Topics

Ongoing Clinical Trials

2 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Irradiation in Paediatrics Neurocognition Neuroimaging and Evaluation of Memory and Attention
NCT06599879 — radiotherapy, brain neoplasms, injections, telephone, neuroimaging, brain, neoplasms, therapeutics, memory
N/ARecruiting2025
Integrative Molecular Analysis of Individual Radiosensitivity in Pediatric Oncology
NCT06033183 — radiation tolerance, blood, neoplasms, specimen handling
N/ARecruiting2023

LeadR Networks

Main global connection map